Search

Your search keyword '"Eaton, David L."' showing total 46 results

Search Constraints

Start Over You searched for: Author "Eaton, David L." Remove constraint Author: "Eaton, David L." Database MEDLINE Remove constraint Database: MEDLINE
46 results on '"Eaton, David L."'

Search Results

1. Species differences in specific ligand-binding affinity and activation of AHR: The biological basis for calculation of relative effective potencies and toxic equivalence factors.

2. The 2022 revised WHO TEFs for dioxins and dioxin-like chemicals: The importance of considering the use of species-specific information to determine relative effective potency for human-based risk assessment.

3. This is your teen brain on drugs: In search of biological factors unique to dependence toxicity in adolescence.

5. Human liver-kidney model elucidates the mechanisms of aristolochic acid nephrotoxicity.

6. Microphysiological Systems to Assess Nonclinical Toxicity.

7. Characterization of rat or human hepatocytes cultured in microphysiological systems (MPS) to identify hepatotoxicity.

8. Mortalin is Expressed by Astrocytes and Decreased in the Midbrain of Parkinson's Disease Patients.

9. The NIEHS Superfund Research Program: 25 Years of Translational Research for Public Health.

10. Amphiphilic polymer-coated CdSe/ZnS quantum dots induce pro-inflammatory cytokine expression in mouse lung epithelial cells and macrophages.

11. FutureTox II: in vitro data and in silico models for predictive toxicology.

12. Cruciferous vegetables have variable effects on biomarkers of systemic inflammation in a randomized controlled trial in healthy young adults.

13. Of mice, rats, and men: could Nrf2 activation protect against aflatoxin heptocarcinogenesis in humans?

14. In vitro approaches to assessing the toxicity of quantum dots.

15. The glutathione synthesis gene Gclm modulates amphiphilic polymer-coated CdSe/ZnS quantum dot-induced lung inflammation in mice.

16. Enhancement of hepatic 4-hydroxylation of 25-hydroxyvitamin D3 through CYP3A4 induction in vitro and in vivo: implications for drug-induced osteomalacia.

17. Heme oxygenase expression as a biomarker of exposure to amphiphilic polymer-coated CdSe/ZnS quantum dots.

18. Sulforaphane is not an effective antagonist of the human pregnane X-receptor in vivo.

19. Innovations in preclinical biology: ex vivo engineering of a human kidney tissue microperfusion system.

20. In vitro toxicity assessment of amphiphillic polymer-coated CdSe/ZnS quantum dots in two human liver cell models.

21. Dietary modulation of the biotransformation and genotoxicity of aflatoxin B(1).

22. Sulforaphane- and phenethyl isothiocyanate-induced inhibition of aflatoxin B1-mediated genotoxicity in human hepatocytes: role of GSTM1 genotype and CYP3A4 gene expression.

23. Modulation of aflatoxin B1-mediated genotoxicity in primary cultures of human hepatocytes by diindolylmethane, curcumin, and xanthohumols.

24. CYP1A2, GSTM1, and GSTT1 polymorphisms and diet effects on CYP1A2 activity in a crossover feeding trial.

25. Identification of glutathione S-transferase pi as a protein involved in Parkinson disease progression.

26. Serum organochlorine pesticide residues and risk of testicular germ cell carcinoma: a population-based case-control study.

27. Review of the toxicology of chlorpyrifos with an emphasis on human exposure and neurodevelopment.

28. The dietary isothiocyanate sulforaphane is an antagonist of the human steroid and xenobiotic nuclear receptor.

29. 5' and 3' region variability in the dopamine transporter gene (SLC6A3), pesticide exposure and Parkinson's disease risk: a hypothesis-generating study.

30. Apiaceous vegetable constituents inhibit human cytochrome P-450 1A2 (hCYP1A2) activity and hCYP1A2-mediated mutagenicity of aflatoxin B1.

31. Genetic Susceptibility to Prostate Cancer: Prostate-specific Antigen and its Interaction with the Androgen Receptor (United States).

32. Analysis of cellular responses to aflatoxin B(1) in yeast expressing human cytochrome P450 1A2 using cDNA microarrays.

33. Expression of a human cytochrome p450 in yeast permits analysis of pathways for response to and repair of aflatoxin-induced DNA damage.

35. Estradiol metabolites as isoform-specific inhibitors of human glutathione S-transferases.

36. Characterization of atrazine biotransformation by human and murine glutathione S-transferases.

37. Biotransformation of methyl parathion by glutathione S-transferases.

38. Tellurium-mediated cycloaromatization of acyclic enediynes under mild conditions.

39. Glutathione S-transferase M1, T1, and P1 polymorphisms and survival among lung cancer patients.

40. A population-based study of glutathione S-transferase M1, T1 and P1 genotypes and risk for lung cancer.

41. The role of genetic polymorphisms in environmental health.

42. Glutathione S-transferase M1, T1, and P1 polymorphisms and Parkinson's disease.

43. Complementary DNA cloning, protein expression, and characterization of alpha-class GSTs from Macaca fascicularis liver.

45. A road map to stable, soluble, easily crystallized pentacene derivatives.

46. Expression of human microsomal epoxide hydrolase in Saccharomyces cerevisiae reveals a functional role in aflatoxin B1 detoxification.

Catalog

Books, media, physical & digital resources